Innovation Pharmaceuticals Inc. Quarterly Operating Income (Loss) in USD from Q3 2010 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Innovation Pharmaceuticals Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2010 to Q3 2023.
  • Innovation Pharmaceuticals Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$866K, a 38.7% increase year-over-year.
  • Innovation Pharmaceuticals Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$2.56M, a 46.8% increase year-over-year.
  • Innovation Pharmaceuticals Inc. annual Operating Income (Loss) for 2023 was -$3.11M, a 55.1% increase from 2022.
  • Innovation Pharmaceuticals Inc. annual Operating Income (Loss) for 2022 was -$6.92M, a 23.2% increase from 2021.
  • Innovation Pharmaceuticals Inc. annual Operating Income (Loss) for 2021 was -$9.02M, a 94.5% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 -$2.56M -$866K +$547K +38.7% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-20
Q2 2023 -$3.11M -$672K -$734K -1184% Apr 1, 2023 Jun 30, 2023 10-K 2023-09-28
Q1 2023 -$2.38M -$679K +$779K +53.4% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$3.16M -$347K +$1.67M +82.8% Oct 1, 2022 Dec 31, 2022 10-Q 2023-02-15
Q3 2022 -$4.82M -$1.41M +$610K +30.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-20
Q2 2022 $62K +$2.59M Jun 10, 2022 Jun 30, 2022 10-K 2022-09-28
Q1 2022 -$8.02M -$1.46M +$460K +24% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$8.48M -$2.01M +$1.43M +41.4% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-15
Q3 2021 -$9.91M -$2.02M -$894K -79.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$9.02M -$2.53M Apr 1, 2021 Jun 30, 2021 10-K 2022-09-28
Q1 2021 -$1.92M -$993K -107% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 -$3.44M Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-14
Q3 2020 -$1.13M -$188K -20% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q1 2020 -$925K +$203K +18% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
Q3 2019 -$5.39M -$941K +$1.06M +52.9% Jul 1, 2019 Sep 30, 2019 10-Q 2019-11-13
Q2 2019 -$6.45M -$1.33M +$1.26M +48.7% Apr 1, 2019 Jun 30, 2019 10-K 2019-09-30
Q1 2019 -$7.71M -$1.13M +$1.27M +53% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-10
Q4 2018 -$8.98M -$1.99M +$2.47M +55.4% Oct 1, 2018 Dec 31, 2018 10-Q 2019-02-08
Q3 2018 -$11.5M -$2M +$2.49M +55.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$13.9M -$2.59M +$2.6M +50.1% Apr 1, 2018 Jun 30, 2018 10-K 2019-09-30
Q1 2018 -$16.5M -$2.4M +$1.45M +37.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$18M -$4.47M -$1.16M -35% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-08
Q3 2017 -$16.8M -$4.48M -$1.51M -50.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$15.3M -$5.2M -$2M -62.7% Apr 1, 2017 Jun 30, 2017 10-K 2018-09-11
Q1 2017 -$13.3M -$3.85M -$193K -5.28% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$13.1M -$3.31M -$35K -1.07% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-07
Q3 2016 -$13.1M -$2.98M -$451K -17.8% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 -$12.7M -$3.19M -$142K -4.65% Apr 1, 2016 Jun 30, 2016 10-K 2017-09-11
Q1 2016 -$12.5M -$3.66M -$814K -28.6% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 -$11.7M -$3.27M -$569K -21% Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-09
Q3 2015 -$11.1M -$2.53M +$1.83M +42% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$13M -$3.05M +$240K +7.29% Apr 1, 2015 Jun 30, 2015 10-K 2017-09-11
Q1 2015 -$13.2M -$2.85M -$563K -24.7% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$12.6M -$2.71M -$1.16M -75% Oct 1, 2014 Dec 31, 2014 10-Q 2016-02-08
Q3 2014 -$11.5M -$4.35M -$3.44M -374% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$8.04M -$3.29M -$2.21M -204% Apr 1, 2014 Jun 30, 2014 10-K 2016-09-13
Q1 2014 -$5.83M -$2.28M -$1.48M -185% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 -$4.35M -$1.55M -$857K -124% Oct 1, 2013 Dec 31, 2013 10-Q 2015-02-09
Q3 2013 -$3.49M -$918K -$509K -124% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-10
Q2 2013 -$2.98M -$1.08M +$429K +28.4% Apr 1, 2013 Jun 30, 2013 10-K 2015-09-11
Q1 2013 -$3.41M -$801K -$84.6K -11.8% Jan 1, 2013 Mar 31, 2013 10-Q/A 2014-05-16
Q4 2012 -$3.33M -$689K +$384K +35.8% Oct 1, 2012 Dec 31, 2012 10-Q 2014-02-10
Q3 2012 -$3.71M -$409K +$485K +54.3% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 -$4.2M -$1.51M -$304K -25.2% Apr 1, 2012 Jun 30, 2012 10-K 2014-09-15
Q1 2012 -$3.89M -$716K +$1.51M +67.9% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-20
Q4 2011 -$5.41M -$1.07M +$219K +16.9% Oct 1, 2011 Dec 31, 2011 10-Q 2013-02-13
Q3 2011 -$5.62M -$894K +$98.5K +9.92% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-19
Q2 2011 -$5.72M -$1.21M Apr 1, 2011 Jun 30, 2011 10-K 2012-10-12
Q1 2011 -$2.23M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-18
Q4 2010 -$1.29M Oct 1, 2010 Dec 31, 2010 10-Q 2012-02-14
Q3 2010 -$993K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.